News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
Presentation Miami Valves 2024 New Cerebral Protection Devices for TAVR Presenter: Fábio S. Brito Jr. February 03, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News Less Is More: Lp(a) Much More Atherogenic Than LDL Michael O'Riordan January 16, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2023 Caitlin E. Cox December 28, 2023
News Daily News Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data Yael L. Maxwell December 13, 2023
Presentation TCT 2023 TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Nathan Matzko October 26, 2023
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023